Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System

This publication has 16 references indexed in Scilit:

• Meningococcal conjugate vaccines: optimizing global impact
  Infection and Drug Resistance, 2011
• Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System
  American Journal of Obstetrics and Gynecology, 2011
• Bacterial Meningitis in the United States, 1998–2007
  New England Journal of Medicine, 2011
• Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009
  American Journal of Obstetrics and Gynecology, 2010
• Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease
  Clinical Infectious Diseases, 2010
• Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
  Published by Elsevier ,2009
• Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
  The Pediatric Infectious Disease Journal, 2004
• Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
  Pharmacoepidemiology and Drug Safety, 2001
• Meningococcal Disease
  New England Journal of Medicine, 2001
• The vaccine adverse event reporting system (VAERS)
  Vaccine, 1994